Understanding the critical roles of cGMP chemicals and single-use technologies in cell & gene therapy manufacturing

Register & watch

Thursday, April 23, 2020
10:00 to 11:00 EST (New York, Philadelphia, Boston), 15:00 to 16:00 GMT (London, Dublin, Lisbon), 16:00 to 17:00 CET (Berlin, Paris, Madrid)

Rapid developments in cell & gene therapy have resulted in recent product approvals, bringing these transformative medicines to market to improve global health and well-being. Commercializing these products, however, have introduced a unique new set of challenges incl. consistent quality, continuity of supply, reducing contamination risks and open processing.

Learn how Avantor is enabling our customers scale therapies from R&D to patient delivery, faster and safer. Our experts will discuss why using cGMP chemicals matters in these applications, how to improve product sampling, and other developments in this innovative area in 2020.

This presentation was given as part of Cell & Gene Digital Week in April 2020.

Register & watch

Presented by:

Timothy Korwan

Tim is Director of New Product Development at Avantor. Tim has 20+ years of experience as an engineer and business development with VWR, PAW BioScience Products, and Biopure Corporation where he has designed single-use products, components, and systems that are used by the global drug and vaccine manufacturing industry.

Wayne Lynch

Wayne is a Product Manager in Avantor's BioPharma group leading Avantor's commercial efforts in cell & gene therapy. He has nearly a decade of experience in the Biopharma space understanding industry challenges and delivering solutions.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.